•  
  •  
 

ORCID (Optional)

0000-0002-7861-5713

Document Type

Original Report

Disciplines

Digestive System Diseases | Gastroenterology | Medicine and Health Sciences | Surgery

Abstract

I

Introduction

Minimally invasive Heller myotomy rates have increased, but little evidence is available regarding long term clinical and surgical outcomes. Our aim was to evaluate long term symptom improvement and medication resolution for patients undergoing minimally invasive Heller myotomy.

Methods

A single-institution database was retrospectively reviewed for patients undergoing laparoscopic Heller myotomy (LHM) or robotic Heller myotomy (RHM) during 2007-2018. Patients with primary HM followed by a Dor fundoplication were included. Demographics and surgical data were analyzed. Esophageal symptoms, testing, and medication use were collected preoperatively (pre-op), at 6-month (6-mo), 12-month (12-mo), and long-term (LT; 12-mo+) follow-up. Analysis was performed using SPSS v.23.0, α=0.05.

Results

Eighty eight patients (RHM:N=66; LHM:N=22) were included. The majority were male (62.5%) and Caucasian (89.8%), with a mean BMI of 27.3. Two patients had an intraoperative esophageal perforation, each repaired with a non-eventful postoperative course. Mean follow-up time was 71 months overall, 75 months [11-171 months] and 40 months [6-158 months] for LHM and RHM, respectively. All patients showed significant LT improvement of regurgitation, solid or liquid dysphagia, and Eckardt Score. Postoperative proton pump inhibitor (PPI) use was significantly lower at LT (LHM:31.3%, RHM:19.4%) compared to pre-op.

Conclusion

In this study, minimally invasive HM was a safe and effective treatment for achalasia symptom resolution in the long term. Therefore, in our experience, minimally invasive HM is a safe therapy that helps maintain symptom resolution.

DOI

10.32873/unmc.dc.gmerj.1.1.006

Keywords

Achalasia, Heller myotomy, robotic surgery

Creative Commons License

Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License
This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.